Table 2.5. Number and rates* of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2019

Table 2.5. Number and rates* of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2019
Table 2.5. Number and rates* of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2019
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
†For case definition, see https://ndc.services.cdc.gov/conditions/hepatitis-b-chronic/.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.

Downloads of this table: PDF PPT

In the United States, chronic hepatitis B is one of the leading causes of cirrhosis, which is a major cause of liver cancer. This table displays the number and rates of newly identified chronic hepatitis B cases during 2019, by state or jurisdiction. Of note, cases of newly reported chronic hepatitis B do not represent all prevalent hepatitis B infections, which cannot be captured in the National Notifiable Diseases Surveillance System.

Of the 13,859 cases of chronic hepatitis B reported during 2019, approximately half of the cases were from 6 states (Florida, New York, Georgia, Pennsylvania, Ohio, and Tennessee). The highest rate of newly reported chronic hepatitis B was in Georgia (12.0 cases per 100,000 population, whereas the lowest rates were in Kansas and Wisconsin (0.9 cases per 100,000 population).

Hepatitis B Figures and Tables